The haematological consequences of plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis

<strong>Background</strong> Malaria causes a reduction in haemoglobin that is compounded by primaquine, particularly in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency. The aim of this study was to determine the relative contributions to red cell loss of malaria and pri...

Full description

Bibliographic Details
Main Authors:	Commons, RJ, Simpson, JA, Thriemer, K, Chu, CS, Douglas, NM, Abreha, T, Alemu, SG, Añez, A, Anstey, NM, Aseffa, A, Assefa, A, Awab, GR, Baird, JK, Barber, BE, Borghini-Fuhrer, I, D’Alessandro, U, Dahal, P, Daher, A, De Vries, PJ, Erhart, A, Gomes, MSM, Grigg, MJ, Hwang, J, Kager, PA, Ketema, T, Khan, WA, Lacerda, MVG, Leslie, T, Ley, B, Lidia, K, Monteiro, WM, Pereira, DB, Phan, GT, Phyo, AP, Rowland, M, Saravu, K, Sibley, CH, Siqueira, AM, Stepniewska, K, Taylor, WRJ, Thwaites, G, Tran, BQ, Hien, TT, Vieira, JLF, Wangchuk, S, Watson, J, William, T, Woodrow, CJ, Nosten, F, Guerin, PJ, White, NJ, Price, RN
Format:	Journal article
Language:	English
Published:	BioMed Central 2019

The haematological consequences of plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis

Similar Items